Gastric mucosal cell-derived L-lactic acid strongly enhances proliferation of Helicobacter pylori, and may contribute to the long-term colonization of H. pylori in the stomach. Therefore it is assumed that inhibitory substances active against L-lactic acid-dependent growth of H. pylori will be useful candidates as novel therapeutic agents for H. pylori infection. In this study, we developed a new assay system for screening anti-H. pylori substances, and baicalein and glycyrrhetinic acid were found as potent inhibitory substances against L-lactic aciddependent H. pylori growth but not L-lactic acid-independent growth. The newly developed assay system described in this study also may facilitate the development of novel therapeutic agents for H. pylori infection.
Notes
Chronic infection with Helicobacter pylori has been demonstrated one of the major causes of gastritis resulting in various disease states including peptic ulcers, gastric adenocarcinoma, and mucosal-associated lymphoid tissue (MALT) lymphoma.
1) The interaction of H. pylori with the gastric surface mucous cells may be important for growth and colonization of H. pylori in the stomach. However, the detailed colonization mechanism of H. pylori in the stomach, especially involvement of the interaction between host gastric mucous cells and H. pylori, is not fully understood.
Previously, we developed a novel in vitro infection model of H. pylori using murine normal gastric surface mucous cell line GSM06 cells as the host cell.
2) Through study of the interaction between H. pylori and GSM06 cells using this model, we found that H. pylori growth was significantly enhanced by co-cultivation with GSM06 cells and by conditioned medium of GSM06 cells.
3) A soluble factor that enhanced H. pylori growth was isolated by bioassay-guided purification from the conditioned medium of GSM06 cells and identified as L-lactic acid.
3) It was reported that when H. pylori and Lactobacillus salivarius were co-cultured, Ͼ10-mM concentrations of lactic acid produced from L. salivarius in the medium inhibited growth of H. pylori. 4) However, 0.1 mM to 5 mM concentrations of L-lactic acid enhanced proliferation of H. pylori in a dose-dependent manner.
3) Concentration of lactic acid in the human gastric juice was reported to be about 0.3-1 mM. 5, 6) Thus physiological concentration of L-lactic acid enhances the growth of H. pylori, and H. pylori can recognize and utilize host cell-derived L-lactic acid for growth and long-term colonization in the stomach. Therefore it is assumed that inhibitory substances against L-lactic acid-dependent growth of H. pylori will be good candidates as novel therapeutic agents for H. pylori infection.
We herein report our newly developed fluorometric assay for screening of anti-H. pylori substances, and the inhibitory effects of baicalein and glycyrrhetinic acid against L-lactic acid-dependent growth of H. pylori.
MATERIALS AND METHODS

Materials
Brain Heart Infusion (BHI) broth was obtained from Difco Laboratories (Detroit, MI, U.S.A.). Dulbecco's modified Eagle's medium/Ham's F-12 medium (DMEM/F-12) and fetal bovine serum (FBS) were obtained from Sigma (St. Louis, MO, U.S.A.). Defibrinated horse blood was obtained from Nippon Biotest Laboratories (Tokyo, Japan). Clarithromycin was kindly provided by Dr. S. Omura (Taisho Pharmaceutical Co., Ltd., Tokyo, Japan). H. pylori SS-1 was provided by Dr. A. Kai (Tokyo Metropolitan Research Laboratory of Public Health, Japan). H. pylori RC-1 was isolated and established from human gastric biopsy specimen in the Kitasato Institute Hospital (Tokyo, Japan). H. pylori RC-1 is a clarithromycin-resistant strain, and both H. pylori SS-1 and RC-1 are pathogenic factors such as cytotoxin-associated gene A (cagA) and the vacuolating cytotoxin gene (vacA)-positive strains.
7)
Culture of H. pylori for Assay The bacteria were grown on BHI agar plate supplemented with 10% defibrinated horse blood, 1 mg/ml glucose, and 250 mg/ml bovine serum albumin for 4 d in a microaerobic environment (15% CO 2 , 5% O 2 , and 80% N 2 ). The colonies were harvested from the plates, suspended in 20 ml BHI broth containing 10% FBS and 1 mg/ml glucose, and incubated at 37°C overnight with agitation on a rotary shaker at 100 rpm in a microaerobic condition. Two milliliters of the seed culture of H. pylori was inoculated into 200 ml BHI broth containing 10% FBS and 1 mg/ml glucose, and incubated at 37°C for 48 h with agitation on a rotary shaker at 100 rpm in a microaerobic condition. The resulting H. pylori was used for the assay.
Measurement of Inhibitory Activity against L-Lactic Acid-Dependent H. pylori Growth In brief, H. pylori was suspended in DMEM/F-12 containing 5 mM L-lactic acid at a turbidity of 0.0018 (1ϫ10 5 CFU/ml). One hundred microliters of the suspension was added to the each well of the 96 well culture plate then incubated with or without test compound at 37°C for 24 h under microaerobic condition. After incubation, the growth of H. pylori was determined by Alamar blue assay as described elsewhere.
3) In brief, Alamar blue solution (Alamar Bio-Sciences, Sacramento, CA, U.S.A.) was added to each well and incubated for 1 h, and the fluorescence intensity was measured on a fluorescence reader, Fluoroskan II (Labsystems, Helsinki, Finland) at an excitation wavelength 544 nm and emission wavelength 590 nm.
Ordinary Assay for Anti-H. pylori Activity H. pylori was suspended in BHI broth containing 10% FBS and 1 mg/ml glucose (1ϫ10 5 CFU/ml). One hundred microliters of suspension of H. pylori was added to the each well of a 96 well culture plate then incubated with or without test compound at 37°C for 24 h under microaerobic condition. The growth of H. pylori was measured by Alamar blue assay as described above.
Calculation of H. pylori Growth Inhibitory Activity H. pylori growth inhibitory activity of the tested compound was calculated by the following formula:
A: cultured without test sample. B: cultured with test sample. C: medium alone.
RESULTS AND DISCUSSION
In the course of our screening for anti-H. pylori substances of plant origin using our newly developed assay system, it was found that baicalein and glycyrrhetinic acid showed potent inhibitory effects against L-lactic acid-dependent growth of H. pylori. The structures of these compounds are shown in Fig. 1 . Each compound inhibited L-lactic acid-dependent growth of both H. pylori SS-1 (clarithromycin sensitive) and RC-1 (clarithromycin resistant) strains in a dose dependent manner (Fig. 2) . Whereas, no or negligible activity was observed by the ordinary assay for anti-H. pylori activity (Fig.  2) . The IC 50 value of the each compound is listed in Table 1 . These results suggest that the inhibitory efect of baicalein and glycyrrhetinic acid is specific to L-lactic acid-dependent growth of H. pylori.
Although baicalein and glycyrrhetinic acid showed potent inhibitory effects (Fig. 2) , neither baicalin nor glycyrrhizin, which are glycoside forms of baicalein and glycyrrhetinic acid, respectively, showed inhibitory activity (data not shown). Therefore it is assumed that the cell membrane permeability of the compound is an important factor to exert inhibitory activity against L-lactic acid-dependent growth of H. pylori.
The new assay method is based on the observation that Llactic acid strongly enhances growth of H. pylori. The mechanism of the growth-enhancing activity of L-lactic acid is now not known. It has been reported that whole genomic analyses of H. pylori, strains 26695 and J99, predict the absence of a gene that codes for L-lactate dehydrogenase (L-LDH). 8, 9) L-LDH is a key enzyme for utilization of L-lactic acid by tricarboxylic acid (TCA) cycle. 10) Therefore it is suggested that H. pylori cannot utilize L-lactic acid as an energy source by the TCA cycle. Because H. pylori has been predicted to code two lactic permease genes, 8, 9) H. pylori may be able to incorporate L-lactic acid by the permease, and then it may be utilized through an unknown metabolic pathway for energy-yielding reaction or act as a signal transducer. The compounds that showed potent inhibitory activity against L- H. pylori SS-1 and RC-1 are clarithromycin-sensitive and -resistant strains, respectively. One hundred microliters of H. pylori suspension (1ϫ10 5 CFU/ml) was added to each well of a 96 well plate then incubated with or without test compound at 37°C for 24 h under microaerobic condition. After incubation, growth of H. pylori was determined by fluorometric method using Alamar blue as mentioned in Materials and Methods. Clarithromycin was used as control compound. a) Inhibition of L-lactic acid-dependent H. pylori growth was measured using DMEM/F12 containing 5 mM L-lactic acid. b) The ordinary assay for anti-H. pylori activity was measured using BHI broth containing 10% FBS and 1 mg/ml glucose. In a recent observation, when the growth of H. pylori was assessed by both colony forming unit (CFU) method and fluorometric method using Alamar blue, comparable data were obtained.
3) This result suggests that Alamar blue method is considered as an alternative method to CFU. Although CFU method is useful for counting the number of living H. pylori, it is hard to analyze multiple samples, and by this technique, a prolonged period (usually 4-5 d) is required for the incubation to obtain visible colonies on agar plate. Because estimation using Alamar blue method can be done within a few hours, this method was used for estimation of living H. pylori in this study. In addition to the advantage of shortening the assay time, Alamar blue method has made it possible for the assay to be performed on a 96 well microplate. The assay using 96 well microplate is suitable for the analyses of multiple samples such as column fractions or the screening of anti-H. pylori substances.
The newly developed assay system is rapid, simple, sensitive, and a useful method for estimation of living H. pylori, and may facilitate the development of novel therapeutic agents for H. pylori infection.
